Rep. Tim Moore Buys Centene Corporation (NYSE:CNC) Shares

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation (NYSE:CNC). In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 29th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 7/30/2025.
• Purchased $15,001 – $50,000 in shares of Verizon Communications (NYSE:VZ) on 7/29/2025.
• Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/29/2025.
• Purchased $1,001 – $15,000 in shares of Centene (NYSE:CNC) on 7/22/2025.
• Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/21/2025.
• Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/18/2025.

Centene Stock Performance

Shares of CNC stock opened at $25.20 on Thursday. Centene Corporation has a one year low of $25.11 and a one year high of $80.59. The stock has a market cap of $12.37 billion, a PE ratio of 6.24, a price-to-earnings-growth ratio of 1.06 and a beta of 0.40. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The stock has a 50-day moving average of $42.15 and a 200-day moving average of $54.03.

Centene (NYSE:CNC) last released its earnings results on Friday, July 25th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.39). The business had revenue of $48.74 billion during the quarter, compared to the consensus estimate of $44.71 billion. Centene had a net margin of 1.15% and a return on equity of 9.57%. The firm’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period last year, the business posted $2.42 EPS. As a group, sell-side analysts expect that Centene Corporation will post 6.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Mizuho lowered their price objective on shares of Centene from $71.00 to $40.00 and set a “neutral” rating for the company in a research report on Friday, July 11th. Wall Street Zen downgraded shares of Centene from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Oppenheimer dropped their target price on Centene from $51.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Barclays decreased their price objective on shares of Centene from $65.00 to $45.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 2nd. Finally, Wells Fargo & Company lowered shares of Centene from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $72.00 to $30.00 in a research report on Wednesday, July 23rd. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Centene presently has an average rating of “Hold” and a consensus price target of $42.20.

Institutional Trading of Centene

Large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors lifted its holdings in shares of Centene by 55.6% in the 4th quarter. Captrust Financial Advisors now owns 45,103 shares of the company’s stock worth $2,732,000 after acquiring an additional 16,108 shares during the last quarter. Farther Finance Advisors LLC grew its stake in Centene by 32.3% in the first quarter. Farther Finance Advisors LLC now owns 6,333 shares of the company’s stock worth $383,000 after purchasing an additional 1,546 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Centene by 30.0% in the first quarter. Envestnet Asset Management Inc. now owns 708,717 shares of the company’s stock valued at $43,026,000 after acquiring an additional 163,462 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Centene by 41.4% in the 4th quarter. BNP Paribas Financial Markets now owns 925,150 shares of the company’s stock worth $56,046,000 after purchasing an additional 270,899 shares during the period. Finally, Focused Investors LLC boosted its position in Centene by 588.1% during the 1st quarter. Focused Investors LLC now owns 1,042,400 shares of the company’s stock valued at $63,284,000 after acquiring an additional 890,900 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Insider Buying and Selling

In other news, Director Theodore R. Samuels II acquired 9,000 shares of Centene stock in a transaction that occurred on Monday, July 28th. The stock was purchased at an average price of $27.62 per share, for a total transaction of $248,580.00. Following the purchase, the director directly owned 32,000 shares in the company, valued at $883,840. The trade was a 39.13% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.36% of the company’s stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.